These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9868654)

  • 1. Medicare and outpatient therapy for infectious diseases.
    Wenzel RP; Nettleman MD
    Clin Infect Dis; 1998 Dec; 27(6):1422-3. PubMed ID: 9868654
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicare coverage of outpatient ambulatory intravenous antibiotic therapy: a program that pays for itself.
    Tice AD; Poretz D; Cook F; Zinner D; Strauss MJ
    Clin Infect Dis; 1998 Dec; 27(6):1415-21. PubMed ID: 9868653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost-effective approach to managing infectious disease.
    Wright RA
    Consultant; 1989 May; 29(5):143-6, 150, 155. PubMed ID: 10292917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Business aspects of infectious diseases.
    Tenenbaum MJ; Petrak R
    Clin Infect Dis; 2002 Feb; 34(3):420. PubMed ID: 11774093
    [No Abstract]   [Full Text] [Related]  

  • 5. Computer-assisted evaluation of antibiotic regimen coverage and cost.
    Day D; Lubowski TJ; Yamaga CC; Main J; Van Vleet J; Ambegaonkar A
    Clin Ther; 1999 Aug; 21(8):1418-25. PubMed ID: 10485512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost of antibiotic treatment for priority infectious syndromes in Paraguay, 2004.
    Baez E; Dentice MA; Heitmann I
    Epidemiol Bull; 2005 Jun; 26(2):8-11. PubMed ID: 16578882
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the impact of non-inpatient i.v. antibiotic treatment for acute infections on the hospital, primary care services and the patient.
    Parker SE; Nathwani D; O'Reilly D; Parkinson S; Davey PG
    J Antimicrob Chemother; 1998 Sep; 42(3):373-80. PubMed ID: 9786477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare reimbursement for outpatient intravenous antibiotics.
    Am J Hosp Pharm; 1985 Aug; 42(8):1712. PubMed ID: 3898827
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary: How to encourage more diagnostics for infectious diseases.
    Powers JH
    BMJ; 2016 Sep; 354():i4744. PubMed ID: 27604999
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of outpatient parenteral antibiotic therapy: a simulation modelling approach.
    Vargas-Palacios A; Meads DM; Twiddy M; Czoski Murray C; Hulme C; Mitchell ED; Gregson A; Stanley P; Minton J
    J Antimicrob Chemother; 2017 Aug; 72(8):2392-2400. PubMed ID: 28505278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate selection of antimicrobials in the treatment of ambulatory patients.
    Goetz MB
    Health Syst Lead; 1994 Oct; 1(8):34-8. PubMed ID: 10140124
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions.
    Bailey TC; Ritchie DJ; McMullin ST; Kahn M; Reichley RM; Casabar E; Shannon W; Dunagan WC
    Pharmacotherapy; 1997; 17(2):277-81. PubMed ID: 9085319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicaid program; clarification of outpatient hospital facility (including outpatient hospital clinic) services definition. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Nov; 73(217):66187-98. PubMed ID: 19112700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing the focus of infectious diseases to pathogen-specific therapy.
    Zuger A
    Clin Infect Dis; 1997 Aug; 25(2):348-50. PubMed ID: 9332552
    [No Abstract]   [Full Text] [Related]  

  • 15. Challenges in the 2016 Medicare OPPS Proposed Rule.
    Kovar M
    Revenue-cycle Strateg; 2015 Oct; 12(8):1-4. PubMed ID: 26591899
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug treatment of pneumonia in the elderly: efficacy and costs.
    Saltiel E; Weingarten S
    Pharmacoeconomics; 1993 Apr; 3(4):268-75. PubMed ID: 10146990
    [No Abstract]   [Full Text] [Related]  

  • 17. Home intravenous antibiotic therapy.
    Smego RA
    Arch Intern Med; 1985 Jun; 145(6):1001-2. PubMed ID: 4004422
    [No Abstract]   [Full Text] [Related]  

  • 18. On the implications of endogenous resistance to medications.
    Laxminarayan R; Weitzman ML
    J Health Econ; 2002 Jul; 21(4):709-18. PubMed ID: 12146599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonadherence to oral linezolid after hospitalization: a retrospective claims analysis of the incidence and consequence of claim reversals.
    Ball AT; Xu Y; Sanchez RJ; Shelbaya A; Deminski MC; Nau DP
    Clin Ther; 2010 Dec; 32(13):2246-55. PubMed ID: 21316540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.